|
[1]
|
Wang C, Xu JY, Yang L, Xu YJ, Zhang XY, Bai CX, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet 2018;391(10131):1706 − 17. https://doi.org/10.1016/S0140-6736(18)30841-9CrossRef
|
|
[2]
|
Fang LW, Gao P, Bao HL, Tang X, Wang BH, Feng YJ, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med 2018;6(6):421 − 30. https://doi.org/10.1016/S2213-2600(18)30103-6CrossRef
|
|
[3]
|
Zhong NS, Wang C, Yao WZ, Chen P, Kang J, Huang SG, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007;176(8):753 − 60. https://doi.org/10.1164/rccm.200612-1749OCCrossRef
|
|
[4]
|
Chen SM, Kuhn M, Prettner K, Yu FY, Yang T, Bärnighausen T, et al. The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020-50: a health-augmented macroeconomic modelling study. Lancet Glob Health 2023;11(8):e1183 − 93. https://doi.org/10.1016/S2214-109X(23)00217-6CrossRef
|
|
[5]
|
Agusti A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, et al. Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary. Eur Respir 2023;61(4):2300239. https://doi.org/10.1183/13993003.00239-2023. |
|
[6]
|
Milne KM, Mitchell RA, Ferguson ON, Hind AS, Guenette JA. Sex-differences in COPD: from biological mechanisms to therapeutic considerations. Front Med 2024;11:1289259. https://doi.org/10.3389/fmed.2024.1289259CrossRef
|
|
[7]
|
Chen ZM, Chen JS, Collins R, Guo Y, Peto R, Wu F, et al. China Kadoorie Biobank of 0. 5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol 2011;40(6):1652 − 66. https://doi.org/10.1093/ije/dyr120CrossRef
|
|
[8]
|
Yang IA, Jenkins CR, Salvi SS. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment. Lancet Respir Med 2022;10(5):497 − 511. https://doi.org/10.1016/S2213-2600(21)00506-3CrossRef
|
|
[9]
|
Duan PF, Wang Y, Lin RQ, Zeng YM, Chen CS, Yang L, et al. Impact of early life exposures on COPD in adulthood: a systematic review and meta-analysis. Respirology 2021;26(12):1131 − 51. https://doi.org/10.1111/resp.14144CrossRef
|
|
[10]
|
Li JC, Zhu L, Wei YX, Lv J, Guo Y, Bian Z, et al. Association between adiposity measures and COPD risk in Chinese adults. Eur Respir J 2020;55(4):1901899. https://doi.org/10.1183/13993003.01899-2019CrossRef
|